Kevin Buckley

Shareholder Kevin Buckley

kevin@torreypineslaw.com
+1 (858) 869-1250
vCard

Kevin is the founder of Torrey Pines Law Group, and is an experienced intellectual property, transactional, and regulatory attorney for high technology businesses. His clients include biotechnology, pharmaceutical, specialty chemical, medical device, digital health, diagnostics, software, analytics, mobile app, and convergence technology businesses. The "convergence" often includes machine learning, deep learning, artificial intelligence, and complex algorithms.

Areas of focus include:

  • IP, transactional, and regulatory counseling
  • International patent preparation and prosecution
  • Corporate and commercial transactions
  • Technology licensing
  • Investment funding and due diligence
  • Legal opinion drafting
  • Litigation avoidance, and
  • IP infringement litigation

Prior to founding Torrey Pines Law Group, he led the Life Sciences Practice of a large law firm. He has also worked in academics where he handled all legal affairs for the research department of a major American university. He was also chief legal counsel to a private research foundation where he advised the Board regarding complex corporate governance matters. For many years, Kevin was recognized nationally for his law practice by The Best Lawyers in America®.

Prior to becoming a patent attorney, Kevin was a biochemist in both academics and industry. He has also been an academic advisor to entrepreneurship centers at the University of Pennsylvania and Washington University in St. Louis. Kevin taught a Biotechnology Law intersession course at Washington University School of Law where he was an Adjunct Professor.

Outside his law practice, Kevin's interests include mountaineering and hiking the California backcountry. What he is most passionate about, however, is spending time outdoors every day with his daughter, family, and friends.

Kevin received a Bachelor of Science degree in Biochemistry/Chemistry from UC San Diego where he was an undergraduate Research Scholar. He then received a Juris Doctorate from the University of Pittsburgh School of Law where he was Editor-in-Chief of the Pittsburgh Journal of Technology Law and Policy.

Distinctions

Kevin has been selected by his peers for inclusion in:

  • 2018 IAE Intellectual Property Lawyer of the Year in California
  • The Best Lawyers in America® - Biotechnology Law (Top 4% nationally, one of 100 attorneys nationwide)
  • Philadelphia's Best Lawyers
  • SuperLawyers Rising Star
  • St. Louis Magazine Best Lawyers
  • St. Louis Business Journal "Who's Who in Technology"
  • St. Louis Business Journal "40 Under Forty"

Selected Speaking Engagements

  • Presenter, Legal, Financial and Tax Strategies for Start-Ups, Sanford Consortium for Regenerative Medicine, San Diego, CA (January 28, 2015)
  • PresenterIP Strategy Informed by the Commercialization Process, Pennsylvania Bio Inaugural Knowledge Fair, Valley Forge, PA (June 8, 2011)
  • Guest LecturerEntrepreneurial Investing - Management 424/524, Washington University Olin Business School, St. Louis, MO (October 13, 2009 and March 2, 2010)
  • Adjunct Professor Biotechnology Law From Patents to Food-Drug-Planting Approvals (Intersession Course) - Washington University School of Law, St. Louis, MO (January 11-15, 2010)
  • PanelistBringing Overseas Start-Ups Into the U.S. Inaugural Global Healthcare Investing Conference, Cleveland, OH (June 20, 2007)

Jurisdictions

Kevin is registered to practice before the U.S. Patent & Trademark Office, and admitted to practice law in Missouri and Pennsylvania. He is also admitted to the Federal Circuit Court of Appeals.